Bank of America
IRD

Bank of America’s Opus Genetics IRD Stock Holding History

Bank of America’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$305K Buy
67,015
+64,829
+2,966% +$224K ﹤0.01% 5140
2025
Q4 		$4.39K Buy
2,186
+1,803
+471% +$3.66K ﹤0.01% 6294
2025
Q3 		$632 Buy
383
+98
+34% +$122 ﹤0.01% 7553
2025
Q2 		$269 Buy
285
+31
+12% +$29 ﹤0.01% 7790
2025
Q1 		$249 Buy
254
+12
+5% +$13 ﹤0.01% 7645
2024
Q4 		$288 Buy
242
+40
+20% +$46 ﹤0.01% 7513
2024
Q3 		$265 Sell
202
-11
-5% -$17 ﹤0.01% 7507
2024
Q2 		$326 Buy
+213
New +$368 ﹤0.01% 7442
2024
Q1 		– Sell
-27
Closed -$81 – 8261
2023
Q4 		$81 Buy
+27
New +$80 ﹤0.01% 7437
2023
Q1 		– Sell
-46
Closed -$162 – 8350
2022
Q4 		$162 Buy
+46
New +$121 ﹤0.01% 7589
2020
Q3 		– Sell
-7
Closed – – 7226
2020
Q2 		$0 Buy
+7
New +$64 ﹤0.01% 7176
2019
Q4 		– Sell
-41
Closed – – 7471
2019
Q3 		$0 Sell
41
-13
-24% -$181 ﹤0.01% 7556
2019
Q2 		$1K Buy
+54
New +$1.22K ﹤0.01% 7074
2018
Q4 		– Sell
-20
Closed -$2K – 7432
2018
Q3 		$2K Buy
+20
New +$1.54K ﹤0.01% 7047
2018
Q2 		– Sell
-15
Closed -$1.32K – 7372
2018
Q1 		$1K Sell
15
-382
-96% -$34.7K ﹤0.01% 6995
2017
Q4 		$39K Buy
+397
New +$40.3K ﹤0.01% 6178
2016
Q4 		– Sell
-4
Closed – – 7363
2016
Q3 		$0 Sell
4
-44
-92% -$5.32K ﹤0.01% 7407
2016
Q2 		$6K Buy
48
+31
+182% +$4.34K ﹤0.01% 6638
2016
Q1 		$3K Buy
+17
New +$2.83K ﹤0.01% 6713
2015
Q2 		– Sell
-104
Closed -$37K – 7439
2015
Q1 		$37K Hold
104
– – ﹤0.01% 5795
2014
Q4 		$35K Sell
104
-63
-38% -$21.8K ﹤0.01% 6532
2014
Q3 		$65K Buy
167
+32
+24% +$11.5K ﹤0.01% 6334
2014
Q2 		$57K Hold
135
– – ﹤0.01% 6562
2014
Q1 		$70K Buy
135
+30
+29% +$16.2K ﹤0.01% 6238
2013
Q4 		$26K Buy
105
+1
+1% +$211 ﹤0.01% 6919
2013
Q3 		$23K Hold
104
– – ﹤0.01% 6834
2013
Q2 		$22K Buy
+104
New +$17.9K ﹤0.01% 6923

Other funds holding IRD

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bank of America's IRD Position: Q1 2026 in Review

Bank of America increased its Opus Genetics (IRD) stake by 2,966% in Q1 2026, buying an estimated $224K and bringing the position to 67,015 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #5140.

Bank of America first reported a position in IRD in Q2 2013 and has held it in 27 quarters since. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • Bank of America held 67,015 shares of Opus Genetics worth $305K as of Q1 2026.
  • Bank of America bought 64,829 Opus Genetics shares in Q1 2026, an estimated $224K.
  • Opus Genetics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5140 holding.
  • Bank of America first reported a position in Opus Genetics in Q2 2013 and has held it in 27 quarters since.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.